Ax

Biogen Reports Another Tysabri Glitsch

I agree with the FDA stance on the drug, however it doesn't feel good to see the Tysabri scare going on all the time. Do we have to jump anytime there is a new patient that gets the PML infection? Of course not. The label states that quite clearly.

However... due to the fact that Tysabri looks like a drug, taht patient are willing to take even if the drug can cause this serious complication (PML) they do it because it improves the quality of life in a way that no other drug can.

I read some comment of people with MS and they were virtually begging the authorities not to withdraw the drug from the market. So I guess the patient population will continue to increase, although probably at a lower rate.

Too bad that in this stock environment where fear feeds on itself... the BIIB stock is headed lower.